Jean–Jacques Garaud

Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C

John G. McHutchison, Michael P. Manns, Keyur Patel et al. · Gastroenterology · 2002 · 977 citations · Full text

Hepatology, Hepatitis C, Genotype-1–infected Patients +9

A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria

Philip Starkey Lewis, Jean–Jacques Garaud, Francesca Parenti · Journal of Antimicrobial Chemotherapy · 1988 · 77 citations

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

C. Leport, Christian Perronne, Patrice Massip et al. · Antimicrobial Agents and Chemotherapy · 1989 · 77 citations · Full text

August 1987, Antimicrobial Susceptibility, Antibiotics +9

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

Bruno François, Xavier Wittebole, Ricard Ferrer et al. · Intensive Care Medicine · 2020 · 64 citations · Full text

Acute Care, Neurologic Intensive Care, Sepsis +5

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

Bruno François, Simon Lambden, Tom Fivez et al. · The Lancet Respiratory Medicine · 2023 · 60 citations · Full text

Phase 2B, Clinical Trials, Prospective Evaluation +7